Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02568865 · ClinicalTrials.gov registry record

Noninvasive Physiologic Sensors to Assess Depression

A clinical trial, sponsored by Massachusetts General Hospital.

Completed
Registry status
50
Enrollment target

NCT02568865: Completed study, sponsored by Massachusetts General Hospital.

NCT02568865 is a clinical trial that has completed, run by Massachusetts General Hospital. The registered enrollment target is 50 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02568865 has completed, sponsored by Massachusetts General Hospital.

COMPLETED
Registry status
50 participants
Enrollment target

Study Summary

This project aims to use sensors to monitor physiological signals, sleep patterns, vocal characteristics, activity, location and phone usage in study patients with depression who are receiving standard treatment (compared with healthy controls).

Interventions

  • OTHER Physiological Sensors
  • OTHER Sleep Monitoring Device
  • OTHER Vocal Monitoring
  • OTHER Mobile Phone

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2016-01-15
Est. Completion 2020-01-03

Sponsor

Massachusetts General Hospital

2,032 total trials

What the Registry Record Tells You About NCT02568865

The ClinicalTrials.gov registry entry for NCT02568865 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 4 interventions - of which Physiological Sensors is the first listed.

NCT02568865 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02568865 about?

NCT02568865 is a clinical study titled "Noninvasive Physiologic Sensors to Assess Depression". This project aims to use sensors to monitor physiological signals, sleep patterns, vocal characteristics, activity, location and phone usage in study patients with depression who are receiving standard treatment (compared with healthy controls).

What is the current status of trial NCT02568865?

This trial is currently completed. The enrollment target is 50 participants. The study started on 2016-01-15. Estimated completion is 2020-01-03.

What interventions are being tested in trial NCT02568865?

The interventions under investigation include: Physiological Sensors (OTHER), Sleep Monitoring Device (OTHER), Vocal Monitoring (OTHER), Mobile Phone (OTHER).

Who is sponsoring clinical trial NCT02568865?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.